Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor γ agonists

  • Chia Hui Lin
  • , Yi Hui Peng
  • , Mohane Selvaraj Coumar
  • , Santhosh Kumar Chittimalla
  • , Chun Chen Liao
  • , Ping Chiang Lyn
  • , Chin Chieh Huang
  • , Tzu Wen Lien
  • , Wen Hsing Lin
  • , John T.A. Hsu
  • , Jai Hong Cheng
  • , Xin Chen
  • , Jian Sung Wu
  • , Yu Sheng Chao
  • , Hwei Jen Lee
  • , Chiun Gung Juo
  • , Su Ying Wu
  • , Hsing Pang Hsieh

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

Utilizing medicinal chemistry design strategies such as benzo splitting and ring expansion, we converted PPARα/γ dual agonist 1 to selective PPARα agonists 19 and 20. Compounds 19 and 20 were 2- to 4-fold better than rosiglitazone at PPARγ receptor, with 80- to 100-fold PPARγ selectivity over PPARα receptor. X-ray cocrystal studies in PPARγ and modeling studies in PPARα give molecular insights for the improved PPARγ potency and selectivity for 19 when compared to 1.

Original languageEnglish
Pages (from-to)2618-2622
Number of pages5
JournalJournal of Medicinal Chemistry
Volume52
Issue number8
DOIs
Publication statusPublished - 2009 Apr 23

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor γ agonists'. Together they form a unique fingerprint.

Cite this